Chronic myeloid leukemia: 2016 update on diagnosis, therapy, and monitoring

American Journal of Hematology
Elias J Jabbour, Hagop M Kantarjian

Abstract

Chronic Myeloid Leukemia (CML) is a myeloproliferative neoplasm with an incidence of 1-2 cases per 100,000 adults. It accounts for approximately 15% of newly diagnosed cases of leukemia in adults. CML is characterized by a balanced genetic translocation, t(9;22)(q34;q11.2), involving a fusion of the Abelson gene (ABL1) from chromosome 9q34 with the breakpoint cluster region (BCR) gene on chromosome 22q11.2. This rearrangement is known as the Philadelphia chromosome. The molecular consequence of this translocation is the generation of a BCR-ABL1 fusion oncogene, which in turn translates into a BCR-ABL oncoprotein. Frontline therapy: Three tyrosine kinase inhibitors (TKIs), imatinib, nilotinib, and dasatinib are approved by the United States Food and Drug Administration for first-line treatment of patients with newly diagnosed CML in chronic phase (CML-CP). Clinical trials with 2nd generation TKIs reported significantly deeper and faster responses; their impact on long-term survival remains to be determined. Salvage therapy: For patients who fail frontline therapy, second-line options include second and third generation TKIs. Although second and third generation TKIs are potent and selective TKIs, they exhibit unique pharmacologi...Continue Reading

Associated Clinical Trials

References

Sep 18, 1992·Cell·C L SawyersO N Witte
Dec 5, 1995·Proceedings of the National Academy of Sciences of the United States of America·A B RaitanoC L Sawyers
Jan 5, 2000·The Journal of Clinical Investigation·B J Druker, N B Lydon
Mar 15, 2003·The New England Journal of Medicine·Stephen G O'BrienUNKNOWN IRIS Investigators
Jul 17, 2004·Science·Neil P ShahCharles L Sawyers
Feb 16, 2005·Cancer Cell·Ellen WeisbergJames D Griffin
Jun 3, 2009·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Hagop M KantarjianJorge Cortes
Jun 3, 2009·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Jane F ApperleyRichard M Stone
Aug 5, 2009·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Timothy HughesAndreas Hochhaus
Oct 3, 2009·Blood·Karl J AichbergerMichael W Deininger
Apr 14, 2010·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·David MarinJamshid S Khorashad
Jun 8, 2010·The New England Journal of Medicine·Giuseppe SaglioUNKNOWN ENESTnd Investigators
Jun 8, 2010·The New England Journal of Medicine·Hagop KantarjianMichele Baccarani
Dec 24, 2010·The New England Journal of Medicine·Claude PreudhommeUNKNOWN France Intergroupe des Leucémies Myéloïdes Chroniques (Fi-LMC)
Mar 23, 2011·Journal of the National Cancer Institute·Carlo Gambacorti-PasseriniDong-Wook Kim
Mar 23, 2011·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Hagop Kantarjian, Jorge Cortes
Mar 23, 2011·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Rüdiger HehlmannSusanne Saussele

❮ Previous
Next ❯

Citations

May 29, 2016·Chinese Journal of Cancer·Zhi-Jie KangQuentin Liu
Dec 10, 2016·Leukemia & Lymphoma·Elham Yektaei-KarinLeif Stenke
Apr 22, 2017·Nature Communications·Pedro da Silva-CoelhoJoop H Jansen
Dec 30, 2017·Environmental and Molecular Mutagenesis·Pedro Aurio Maia FilhoRomélia Pinheiro Gonçalves Lemes
Oct 4, 2017·Leukemia & Lymphoma·Giuseppe Saglio, Elias Jabbour
Feb 17, 2018·Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc·Habibe KurtShimin Hu
Jan 5, 2019·Journal of Cellular Physiology·Hamideh KouhpeikarAmirhossein Sahebkar
Jan 9, 2019·Radiographics : a Review Publication of the Radiological Society of North America, Inc·Girish S ShroffCarol C Wu
Mar 26, 2019·British Journal of Clinical Pharmacology·Mariana M FachiRoberto Pontarolo
Nov 13, 2019·Journal of Biomedical Materials Research. Part a·K C RemantHasan Uludağ
Jan 25, 2020·British Journal of Haematology·Jenna RossoffNobuko Hijiya
Jul 24, 2020·Molecular Genetics & Genomic Medicine·Mohamed A IsmailNader I Al-Dewik
Jun 7, 2017·Breast Cancer : the Journal of the Japanese Breast Cancer Society·Linlin PanMing Yang
Dec 26, 2018·Case Reports in Oncological Medicine·Parikshit PadhiRamadevi Medavarapu
Dec 22, 2016·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Aaron N WinnStacie B Dusetzina
Feb 24, 2019·Medical Oncology·Raquel AlvesAna B Sarmento-Ribeiro
May 3, 2019·Bulletin of Mathematical Biology·Artur César FassoniIngmar Glauche
Nov 7, 2019·Molecular and Clinical Oncology·Dragomira NikolovaDraga Toncheva
Dec 24, 2019·Technology in Cancer Research & Treatment·Mohammed Hussein KamareddineSaid Farhat
Nov 18, 2019·Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer·Bee Kim TanPing Chong Bee
Jul 28, 2020·Immunological Medicine·Takero ShindoShinya Kimura
Jul 12, 2017·Nihon yakurigaku zasshi. Folia pharmacologica Japonica·Takahiro YoshidaMasaru Kamishohara
Sep 22, 2018·Frontiers in Cardiovascular Medicine·Jesus Paez-MayorgaNhat-Tu Le

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.